Recent Updates
Recently added Catalysts
NAUT Positive Sentiment

What is broadscale proteomics?

Key Takeaway: Broadscale proteomics, also known as discovery or untargeted proteomics, aims to quantify all proteins in a sample, allowing researchers to identify changes associated with biological phenomena. The Nautilus Proteome Analysis Platform is being developed to address challenges in measuring both high and low abundance proteins, enhancing the dynamic range of proteomic analysis. This platform promises to improve reproducibility and robustness, facilitating drug discovery and biomarker identification.
Price reaction · baseline $2.7185 (2024-10-10T15:54:00.000Z) · hit during market hours · 1 other NAUT headline(s) in the window, move may be shared
day 0 close · peak
-0.3%

Market Sentiment Analysis

POSITIVE FACTORS

  • Broadscale proteomics can identify potential drug targets.
  • The Nautilus Platform aims to improve accessibility in proteomics.
  • Designed for reproducibility and robustness, enhancing research reliability.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~29 mo
Minimal dilution risk
Lead asset
MDMA
Phase 2 · Post-Traumatic Stress Disorder

Full Press Release Details

Proteomics
Tyler Ford
October 10, 2024
Broadscale proteomics efforts aim to quantify all proteins expressed in a given sample across the wide dynamic range of the proteome .
Often called “ discovery proteomics ” or “untargeted proteomics,” broadscale proteomics efforts enable researchers to identify protein changes associated with biological phenomena. These are contrasted with targeted proteomics studies, which set out to examine specific proteins or subsets of a sample’s proteome.
Broadscale proteomics studies do not require researchers to have hypotheses about which proteins or pathways change as a result of the phenomenon studied. Instead, researchers use broadscale proteomics techniques to compare the full proteomes of affected and unaffected samples and comprehensively identify changes in proteins and pathways.
Watch this animation for a visual dive into Nautilus’ broadscale proteomics methodology :

Dynamic range in broadscale proteomics

When studying complex biological phenomena, both high and low abundance proteins in the proteome can have tremendous impacts on function. For example, low abundance transcription factors or signaling molecules can set off cascades of events that greatly alter cell states. Changes in highly abundant proteins, on the other hand, can be indicative broad dysfunction. E.g., increased blood α2-Macroglobulin can indicate kidney dysfunction. Thus, when using broadscale proteomics techniques to search for differences between proteins in samples affected by a given phenomenon, it is essential to measure both high and low abundance proteins.
Covering the wide dynamic range of the proteome is very difficult. Proteins can be found at abundances spreading over 10 orders of magnitude . Most current proteomics technologies achieve wide dynamic range by adopting complicated, time and resource-intensive workflows. We are developing the Nautilus TM Proteome Analysis Platform to address exactly this issue and are building accessibility into everything from sample preparation to data analysis. Check out this blog post to learn how we’re designing the Nautilus Platform to achieve broadscale proteomic analysis covering the incredible dynamic range of the proteome.
Watch this animation to learn more about how we’re designing the Nautilus Platform with a broad dynamic range:

Charting entire research paths with broadscale proteomics

Broadscale proteomics efforts have many applications. They may, for example, identify potential drug targets , and follow-up work will elucidate the targets’ roles in the condition of interest. Later, drugs that activate or inhibit these targets will need to be designed, synthesized, and tested. Researchers can further use broadscale proteomics to test these drugs and ensure they have the desired effects with minimal off-target effects.
Given that broadscale proteomics studies can direct entire research programs in this way, it is incredibly important that researchers trust their findings. Indeed, the ideal broadscale proteomics technique will be reproducible and robust enough that it can be easily repeated across labs.
The complexity of traditional proteomics techniques often limits their reproducibility, but we have designed the Nautilus Proteome Analysis Platform with reproducibility and robustness at its core . We believe our platform will reliably launch myriad research efforts and vastly accelerate basic research , biomarker discovery , drug development , and more .
Share this Article
Stay up-to-date on all things Nautilus
World-class articles, delivered weekly
MORE ARTICLES
Proteomics applications in medicine, basic biology, and beyond
Proteomics is being applied in many biological fields to unlock new discoveries and drive scientific advances.
Read more
Proteomics and popular culture
We're giving the proteome a PR boost by highlighting ways proteomics can interact with your life in both healthcare and popular culture.
Read more
Traditional protein analysis methods – Western blotting, flow cytometry, and other methods using affinity reagents
There are many existing protein analysis methods using affinity reagents, and all come with advantages and disadvantages.
Read more
Stay up-to-date on all things Nautilus

Subscribe to our Newsletter

Frequently Asked Questions

What is broadscale proteomics?

Broadscale proteomics quantifies all proteins in a sample, identifying changes linked to biological phenomena.

How does the Nautilus Platform improve proteomics?

The Nautilus Platform enhances accessibility and reproducibility in proteomic analysis, covering a wide dynamic range.

What are the applications of broadscale proteomics?

Broadscale proteomics can identify drug targets and test their effects, guiding research programs.

Why is reproducibility important in proteomics?

Reproducibility ensures that findings can be reliably repeated across different labs, enhancing research credibility.

Last updated: Oct 10, 2024